View in EDS HTML Full Text PDF Full Text

Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma.

Saved in:
Bibliographic Details
Title: Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma.
Authors: Papi, Alberto1 (AUTHOR) ppa@unife.it, Corren, Jonathan2 (AUTHOR), Castro, Mario3 (AUTHOR), Domingo, Christian4 (AUTHOR), Rogers, Linda5 (AUTHOR), Chapman, Kenneth R.6 (AUTHOR), Jackson, Daniel J.7 (AUTHOR), Daizadeh, Nadia8 (AUTHOR), Pandit‐Abid, Nami9 (AUTHOR), Gall, Rebecca10 (AUTHOR), Jacob‐Nara, Juby A.9 (AUTHOR), Rowe, Paul J.9 (AUTHOR), Deniz, Yamo10 (AUTHOR), Ortiz, Benjamin10 (AUTHOR)
Source: Allergy. Jan2023, Vol. 78 Issue 1, p233-243. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01054538
DOI:10.1111/all.15456